COVID-19诊断后住院与非住院患者血栓并发症发生率
Infection with coronavirus disease-2019 (COVID-19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID-19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID-19 is uncertain.…
要点
- 实际发生率可能低于既往广泛报告的3%-85%范围。
研究设计与样本
- 两项正在进行的 prospective cohort studies(前瞻性队列研究),纳入住院和非住院COVID-19患者。
临床怎么用
- 临床应关注住院COVID-19患者的VTE风险,出院后3个月内仍需警惕。
- 非住院患者VTE风险较低,可根据个体情况评估预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infection with coronavirus disease-2019 (COVID-19) may predispose for venous thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in COVID-19, ranging from 3% to 85%. Therefore, the true incidence of thrombotic complications in COVID-19 is uncertain. Here we present data on the incidence of VTE in both hospitalised and non-hospitalised patients from two ongoing prospective cohort studies. The incidence of VTE after diagnosis of COVID-19 was 3·9% [95% confidence interval (CI): 2·1-7·2] during hospitalisation, 0·9% (95% CI: 0·2-3·1) in the three months after discharge and 0·2% (95% CI: 0·00-1·25) in non-hospitalised patients, suggesting an incidence rate at the lower end of that in previous reports.
引用
- Tholin B, Ghanima W, Einvik G, et al. Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. Br J Haematol. 2021. PMID: 34028814. doi:10.1111/bjh.17522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。